What Is Bioidentical Progesterone?
Bioidentical hormones are molecules that are an exact structural match for the hormones naturally produced by the human body. The term is often used to describe hormone replacement therapy (HRT) derived from plant sources like soy or yams, which are then processed in a lab to create a molecularly identical version of a human hormone. This is distinct from synthetic hormones, or progestins, which have a different molecular structure and may have different effects and safety profiles in the body.
There are two main types of bioidentical progesterone: FDA-approved products and custom-compounded preparations. The key difference lies in their manufacturing process and regulatory oversight, which has significant implications for safety and consistency.
FDA-Approved Bioidentical Progesterone Brands
The U.S. Food and Drug Administration (FDA) has approved specific brands and generic forms of bioidentical micronized progesterone. These products undergo rigorous testing for safety, effectiveness, and consistency before they can be sold.
- Prometrium (Oral Capsule): This is a brand name for oral micronized progesterone available in 100 mg and 200 mg capsules. It is often prescribed for postmenopausal women with an intact uterus who are also taking estrogen, to protect the uterine lining from overgrowth, and for the treatment of secondary amenorrhea. A generic version, Progesterone Micronized, USP, is also widely available.
- Crinone (Vaginal Gel): A bioidentical progesterone vaginal gel used for fertility treatments as part of an assisted reproductive technology (ART) program. Crinone is also prescribed for secondary amenorrhea.
- Endometrin (Vaginal Insert): These ovules are prescribed to support embryo implantation and early pregnancy as part of ART treatment for infertile women.
- Bijuva (Combination Oral Capsule): This medication combines bioidentical estradiol and bioidentical micronized progesterone in a single oral capsule. It is FDA-approved for treating moderate to severe hot flashes related to menopause.
Custom-Compounded Bioidentical Hormones
Compounded bioidentical hormone therapy (cBHT) is created by a compounding pharmacy, which custom-mixes preparations for individual patients based on a doctor's prescription. While the base ingredients may be FDA-approved, the final compounded product is not regulated or approved by the FDA. This practice is controversial within the medical community for several reasons.
- Lack of Standardization: The strength and purity of compounded hormones can vary significantly, even between different batches from the same pharmacy. There are no mandated reporting requirements for adverse effects, which makes it difficult to collect reliable safety data.
- Delivery Methods: Compounded bioidentical progesterone is often available in a variety of forms, such as creams, gels, and lozenges, which offer different absorption rates. However, the efficacy and safety of these delivery methods are not supported by large-scale clinical trials.
- Professional Recommendations: Major medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), the North American Menopause Society (NAMS), and the Endocrine Society, caution against the routine use of cBHT. They recommend FDA-approved formulations due to their verified quality and safety data.
Bioidentical Progesterone vs. Synthetic Progestins
It is important to distinguish bioidentical progesterone from synthetic progestins, which are not molecularly identical to the body's natural hormone. The Women's Health Initiative study, which raised concerns about risks associated with HRT, primarily used non-bioidentical hormone formulations.
Comparison of FDA-Approved and Compounded Bioidentical Progesterone
Feature | FDA-Approved Bioidentical Progesterone | Compounded Bioidentical Progesterone (cBHT) |
---|---|---|
Regulation | FDA-approved and strictly regulated for safety, efficacy, and quality. | Not FDA-approved or regulated; overseen at the state level. |
Dosage Consistency | Standardized, uniform dosages ensuring consistent potency and absorption. | Dosing can be inconsistent and may vary between batches. |
Efficacy and Safety | Tested in large, controlled clinical trials to confirm safety and effectiveness. | Lacks large-scale clinical trials; limited evidence to support claims of improved safety or efficacy. |
Formulations | Limited to specific FDA-approved forms, such as oral capsules, vaginal gels, or inserts. | Customizable formulations (creams, gels, capsules) and dosages. |
Cost and Insurance | Often more affordable and typically covered by insurance plans. | Generally more expensive and rarely covered by health insurance. |
Medical Consensus | Recommended by major medical organizations. | Cautioned against for routine use by medical societies due to lack of oversight and data. |
Conclusion
For those considering bioidentical progesterone, FDA-approved brands offer a regulated and thoroughly tested option backed by clinical data. These include oral options like Prometrium and combination therapies like Bijuva, as well as vaginal products like Crinone and Endometrin. While custom-compounded alternatives may appeal to those seeking individualized treatment, they lack FDA oversight, standard quality controls, and robust safety data. It is essential for patients to have an informed discussion with their healthcare provider to determine the most appropriate and safest form of hormone therapy based on their individual health needs and medical history. The American College of Obstetricians and Gynecologists has released a clinical consensus on the topic, which can be a helpful resource for further reading.